Clinical effects of liraglutide are possibly influenced by hypertriglyceridemia and remaining pancreatic β-cell function in subjects with type 2 diabetes mellitus
Authors:
Open Access
- 11 April 2016
- journal article
- research article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 30 (6) , 1201-1203
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Lipotoxicity disrupts incretin-regulated human β cell connectivityJournal of Clinical Investigation, 2013
- Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetesDiabetologia, 2012
- Lipid-induced pancreatic β-cell dysfunction: focus on in vivo studiesAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired β-Cell Function?Diabetes, 2010
- TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin ActionDiabetes, 2009
- Downregulation of GLP-1 and GIP Receptor Expression by HyperglycemiaDiabetes, 2007
- Biology of Incretins: GLP-1 and GIPGastroenterology, 2007